• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

Professional Introduction to 3-chloro-4-methylbenzene-1-carboximidamide (CAS No. 170735-25-8) in Modern Chemical and Pharmaceutical Research

3-chloro-4-methylbenzene-1-carboximidamide, identified by its Chemical Abstracts Service (CAS) number 170735-25-8, is a specialized organic compound that has garnered significant attention in the field of chemical and pharmaceutical research. This heterocyclic aromatic derivative features a benzene ring substituted with a chloro group at the 3-position and a methyl group at the 4-position, further functionalized by an imidamide moiety at the 1-position. The unique structural arrangement of this compound imparts distinct chemical properties that make it a valuable intermediate in synthetic chemistry and a promising candidate for various biological applications.

The imidamide functional group, characterized by a nitrogen atom double-bonded to a carbon atom which is also bonded to an amide group, introduces both electrophilic and nucleophilic reactivity to the molecule. This dual reactivity allows 3-chloro-4-methylbenzene-1-carboximidamide to participate in a wide range of chemical transformations, including nucleophilic aromatic substitution, condensation reactions, and coupling reactions with other heterocycles. These properties have made it particularly useful in the synthesis of more complex molecules, such as pharmaceutical intermediates and agrochemicals.

Recent advancements in medicinal chemistry have highlighted the potential of 3-chloro-4-methylbenzene-1-carboximidamide as a building block for drug discovery. The presence of both electron-withdrawing (chloro) and electron-donating (methyl) groups on the benzene ring creates a balanced electronic environment that can modulate the reactivity and binding affinity of the molecule. This balance is crucial for designing compounds with optimal pharmacokinetic profiles.

One of the most compelling areas of research involving 3-chloro-4-methylbenzene-1-carboximidamide is its application in the development of bioactive molecules. Studies have demonstrated its utility in synthesizing derivatives with antimicrobial, anti-inflammatory, and anticancer properties. The carboximidamide moiety, in particular, has been shown to interact with biological targets such as enzymes and receptors, leading to inhibitory effects on pathogenic processes. For instance, researchers have explored its potential as a scaffold for kinase inhibitors, which are critical in targeted cancer therapies.

The synthetic pathways for preparing 3-chloro-4-methylbenzene-1-carboximidamide have been optimized to enhance yield and purity, making it more accessible for industrial-scale applications. Traditional methods often involve chlorination and methylation of benzene derivatives followed by carboxylation or imidamidation steps. However, modern techniques such as flow chemistry and catalytic processes have improved efficiency while reducing waste generation. These innovations align with the growing emphasis on sustainable practices in chemical manufacturing.

The role of computational chemistry has also been instrumental in understanding the reactivity and potential applications of 3-chloro-4-methylbenzene-1-carboximidamide. Molecular modeling studies have predicted how different substituents on the benzene ring influence electronic distributions and interactions with biological targets. These predictions guide experimental design, reducing trial-and-error approaches and accelerating the discovery process.

In conclusion, 3-chloro-4-methylbenzene-1-carboximidamide (CAS No. 170735-25-8) represents a fascinating compound with diverse applications in chemical synthesis and pharmaceutical development. Its unique structural features enable participation in complex transformations, making it a versatile intermediate for drug discovery efforts. As research continues to uncover new methodologies and applications, this compound is poised to play an increasingly important role in advancing both academic research and industrial innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)